Pharmacists Should Not Participate in Abortion or Assisted Suicide

Henshaw SK Van Vort J. Abortion services in the United States, 1991 and 1992. Fam Plan Perspect 1994; 26:100–6, 112.

Ventura SJ , Trends in pregnancies and pregnancy rates: Estimates for the United States, 1980–1992. Month Vital Stat Rep 1995; 43:17.

Koonin LM Smith JC Ramick M Lawson HW , Abortion surveillance, United States, 1989. MMWR CDC Surveill Summ 1992; 41:1–33.

National Committee for Adoption. Adoption factbook. Washington, DC: National Committee for Adoption, June 1989:96.

Torres A Forrest JD , Why do women have abortions? Fam Plan Perspect 1988; 20:169–76.

Boyer KL Bakay RA , The history, theory, and present status of brain transplantation. Neurosurg Clin North Am 1995; 6:113–25.

Habibullah CM Syed IH Qamar A Taher-Uz Z. Human fetal hepatocyte transplantation in patients with fulminant hepatic failure. Transplantation 1994; 58:951–2.

Hainline BE Padilla LM Chong SK Heifetz SA Palmer C Zhou FC , Fetal tissue derived from spontaneous pregnancy losses is insufficient for human transplantation. Obstet Gynecol 1995; 85:619–24.

Branch DW Ducat L Fantel A Low WC Zhou FC Dayton DH , Suitability of fetal tissues from spontaneous abortions and from ectopic pregnancies for transplantation. Human Fetal Tissue Working Group. JAMA 1995; 273:66–8.

Iacono RP Lonser RR Mandybur G Morenski JD Yamada S Shima F. Stereotactic pallidotomy results for Parkinson's disease exceed those of fetal graft. Am Surg 1994; 60:777–82.

Induced termination of pregnancy before and after Roe v Wade. JAMA 1992; 268:3231–9.

Grimes DA , The morbidity and mortality of pregnancy: Still risky business. Am J Obstet Gynecol 1994; 170:1489–94.

Koonin LM Atrash HK Lawson HW Smith JC , Maternal mortality surveillance, United States, 1979–1986. MMWR CDC Surv Summ 1991; 40:1–13.

Winikoff B. Acceptability of medical abortion in early pregnancy. Fam Plan Perspect 1995; 27:142–8.

Chaudhuri G. Abortion. In: Hacker NF Moore JG , eds. Essentials of obstetrics and gynecology. Philadelphia: WB Saunders, 1986:329–35.

Aubeny E. RU 486 combined with PG analogs in voluntary termination of pregnancy. Adv Contracept 1991; 7:339–43.

Termination of pregnancy with reduced doses of mifepristone. World Health Organization task force on post-ovulatory methods of fertility regulation. BMJ 1993; 307:532–7.

Jing X Weng L. A study on the optimal regimen of mifepristone with prostaglandin for termination or early pregnancy. Chung Hua Fu Chan Ko Tsa Chih 1995; 30:38–41.

Werner H Jr Hohlfeld P Jacquemard F Mirlesse V Menez D Daffos F. RU 486 and sulprostone in pregnancy termination in the 2nd and 3rd trimesters. J Gynecol Obstet Biol Reprod (Paris) 1994; 23:701–5.

Schaff EA Eisinger SH Franks P Kim SS , Combined methotrexate and misoprostol for early induced abortion. Arch Fam Med 1995; 4:774–9.

Creinin MD , Methotrexate and misoprostol for abortion at 57–63 days gestation. Contraception 1994; 50:511–5.

Cameron IT Baird DT , Early pregnancy termination: A comparison between vacuum aspiration and medical abortion using prostaglandin (16,16-dimethyl-trans-delta 2PGE1 methyl ester) or the antiprogestogen RU 486. Br J Obstet Gynecol 1988; 95:271–6.

Rodger MW Baird DT , Blood loss following induction of early abortion using mifepristone (RU 486) and a prostaglandin analogue (gemeprost). Contraception 1989; 40:439–47.

Holt R. RU 486/prostaglandin: Considerations for appropriate use in low-resource settings. Law Med Health Care 1992; 20:169–83.

Stotland NL , The myth of the abortion trauma syndrome. JAMA 1992; 268:2078–9.

Showers HR , Postabortion syndrome. Physician 1989; (April):4–5.

Speckhard AC Rue VM , Postabortion syndrome: An emerging public health concern. J Soc Issues 1992; 48:95–119.

Cassel CK Meier DE , Morals and moralism in the debate over euthanasia and assisted suicide. N Engl J Med 1990; 323:750–2.

Griffiths J. The regulation of euthanasia and related medical procedures that shorten life in the Netherlands. Med Law Int 1994; 1:137–58.

Ryan CJ Kaye M. Euthanasia in Australia — The Northern Territories Rights of the Terminally III Act. N Engl J Med 1995; 334:326–8.

van der Maas PJ van Delden JJM Pijnenborg L. Euthanasia and other medical decisions concerning the end of life: An investigation performed upon request of the Commission of Inquiry into the Medical Practice Concerning Euthanasia. Amsterdam: Elsevier Science Publishers, 1992.

Ogilvie AD Potts SG , Assisted suicide for depression: The slippery slope in action? BMJ 1994; 309:492–3.

Lee MA Nelson HD Tilden VP Ganzini L Schmidt TA Tolle SW , Legalizing assisted suicide — Views of physicians in Oregon. N Engl J Med 1996; 334:310–5.

Rupp MT Isenhower HL , Pharmacists' attitudes toward physician-assisted suicide. Am J Hosp Pharm 1994; 51:69–74.

Whitney HAK Jr. Death with indignity legalized. Ann Pharmacother 1994; 28:1395–7.

Callaham M Kassel D. Epidemiology of fatal tricyclic antidepressant ingestion: Implications for management. Ann Emerg Med 1985; 14:1–9.

Bertini G Russo L Cricelli F Daraio A Giglioli C Pini C , Role of a prehospital medical system in reducing heroin-related deaths. Crit Care Med 1992; 20:493–8.

Michel K Waeber V Valach L Arestegui G Spuhler T. A comparison of the drugs taken in fatal and nonfatal self-poisoning. Acta Psychiatr Scand 1994; 90:184–9.

Koppel C Oberdisse U Heinemeyer G. Clinical course and outcome in class IC antiarrhythmic overdose. J Toxicol Clin Toxicol 1990; 28:433–44.

Ordog GJ Benaron S Bhasin V Wasserberger J Balasubramanium S. Serum digoxin levels and mortality in 5,100 patients. Ann Emerg Med 1987; 16:32–9.

van der Wal G van Eijk JT Leenen HJ Spreeuwenberg C. The use of drugs for euthanasia and assisted suicide in family practice. Ned Tijdschr Geneeskd 1992; 136:1299–305.

Block SD Billings JA , Patient requests to hasten death. Arch Intern Med 1994; 154:2039–47.

van der Maas PJ van Delden JJM Pijnenborg L Looman CWN , Euthanasia and other medical decisions concerning the end of life. Lancet 1991; 338:669–74.

Rupp MT , Physician-assisted suicide and the issues it raises for pharmacists. Am J Health-Syst Pharm 1995; 52:1455–60.

Code of ethics adopted, bylaws amended. Pharm Today 1994; 33:1.

Oath of a pharmacist. Alexandria, VA: American Association of Colleges of Pharmacy (revised 1994).

Frautschi S Cerulli A Maine D. Suicide during pregnancy and its neglect as a component of maternal mortality. Int J Gynaecol Obstet 1994; 47:275–84.

Keown D Keown J. Killing, karma and caring: Euthanasia in Buddhism and Christianity. J Med Ethics 1995; 21:265–9.

Brushwood DB , Conscientious objection and abortifacient drugs. Clin Ther 1993; 15:204–12.

Mullan K Allen WL Brushwood DB , Conscientious objection to assisted death: Can pharmacy address this in a systematic fashion? Ann Pharmacother 1996; 30:1185–91.

Rawlings MS , To hell and back: Life after death. Nashville: Thomas Nelson Publishers, 1993.

Cottle M. Hope for the seriously ill. Radio broadcast from Focus on the Family, June 4, 1996.

Altshuler LL Cohen L Szuba MP Burt BK Gitlin M Mintz J. Pharmacologic management of psychiatric illness during pregnancy: Dilemmas and guidelines. Am J Psychiatry 1996; 153:592–606.

Rosenberg EB , The adoption life cycle: The children and their families through the years. New York: Free Press, 1992.

Byrd RC , Positive therapeutic effects of intercessory prayer in a coronary care unit population. South Med J 1988; 81:826–9.

Fry PS , A factor analytic investigation of home-bound elderly individuals' concerns about death and dying and their coping responses. J Clin Psychiatry 1990; 46:737–48.